Abstract
Cytokines serve essential roles in cell to cell communication during development, maintenance of homeostasis, and responses to external stimuli. The expression of cytokines and the signals transmitted by cytokines to target cells need to be tightly regulated at several levels, including transcriptional and post-transcriptional levels. We briefly summarize the role of post-transcriptional mechanisms in coordinating the regulation of cytokine signaling during inflammatory responses, with an emphasis on AU-rich elements (AREs) and GU-rich elements (GREs). AREs and GREs work in concert to coordinate networks of cytokine signaling. The precise regulation of cytokine signaling is particularly important because its dysregulation can be a contributing factor for human diseases, including autoimmune diseases and cancer.
Change history
29 October 2020
The original online version of this chapter was inadvertently published with part of last name of the author “Irina Vlasova-St. Louis” included along with the first name. The correct first and last name of this author is given below:
References
Abdelmohsen K, Pullmann R Jr, Lal A et al (2007) Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell 25:543–557
Al-Haj L, Khabar KS (2012) Cloning of cytokine 3′ untranslated regions and posttranscriptional assessment using cell-based GFP assay. Methods Mol Biol 820:91–104
Anderson P (2008) Post-transcriptional control of cytokine production. Nat Immunol 9:353–359
Anderson P (2010) Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat Rev Immunol 10:24–35
Baker SJ, Rane SG, Reddy EP (2007) Hematopoietic cytokine receptor signaling. Oncogene 26:6724–6737
Bakheet T, Frevel M, Williams BR et al (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29:246–254
Bakheet T, Williams BR, Khabar KS (2003) ARED 2.0: an update of AU-rich element mRNA database. Nucleic Acids Res 31:421–423
Bakheet T, Williams BR, Khabar KS (2006) ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34:D111–D114
Beisang D, Bohjanen PR (2012) Perspectives on the ARE as it turns 25 years old. Wiley Interdiscip Rev RNA 3:719–731
Beisang D, Rattenbacher B, Vlasova-St. Louis IA et al (2012) Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation. J Biol Chem 287:950–960
Beyaert R, Beaugerie L, Van Assche G et al (2013) Cancer risk in immune-mediated inflammatory diseases (IMID). Mol Cancer 12:98
Bitterman PB, Polunovsky VA (2012) Translational control of cell fate: from integration of environmental signals to breaching anticancer defense. Cell Cycle 11:1097–1107
Blackinton JG, Keene JD (2014) Post-transcriptional RNA regulons affecting cell cycle and proliferation. Semin Cell Dev Biol 34:44–54
Bronicki LM, Jasmin BJ (2013) Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA 19:1019–1037
Brooks SA, Blackshear PJ (2013) Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action. Biochim Biophys Acta 1829:666–679
Candido J, Hagemann T (2013) Cancer-related inflammation. J Clin Immunol 33(Suppl 1):S79–S84
Cao W, Manicassamy S, Tang H et al (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat Immunol 9:1157–1164
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307
Chen CY, Shyu AB (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20:465–470
Colin S, Darne B, Kadi A et al (2014) The antiangiogenic insulin receptor substrate-1 antisense oligonucleotide aganirsen impairs AU-rich mRNA stability by reducing 14-3-3beta-tristetraprolin protein complex, reducing inflammation and psoriatic lesion size in patients. J Pharmacol Exp Ther 349:107–117
Dean JL, Wait R, Mahtani KR et al (2001) The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol Cell Biol 21:721–730
Duan J, Shi J, Ge X et al (2013) Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines. Sci Rep 3:1318
Emmons J, Townley-Tilson WH, Deleault KM et al (2008) Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. RNA 14:888–902
Fan J, Ishmael FT, Fang X et al (2011) Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. J Immunol 186:2482–2494
Frasca D, Romero M, Landin AM et al (2010) Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK/tristetraprolin dephosphorylation and E47 mRNA instability. Mech Ageing Dev 131:306–314
Friedel CC, Dolken L, Ruzsics Z et al (2009) Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res 37, e115
Fuxe J, Karlsson MC (2012) TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Semin Cancer Biol 22:455–461
Gratacos FM, Brewer G (2010) The role of AUF1 in regulated mRNA decay. Wiley Interdiscip Rev RNA 1:457–473
Halees AS, El-Badrawi R, Khabar KS (2008) ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse. Nucleic Acids Res 36:D137–D140
Halees AS, Hitti E, Al-Saif M et al (2011) Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol 8:681–691
Hao S, Baltimore D (2009) The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10:281–288
Hodge DL, Berthet C, Coppola V et al (2014) IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice. J Autoimmun 53:33–45
Ivanov P, Anderson P (2013) Post-transcriptional regulatory networks in immunity. Immunol Rev 253:253–272
Jacob CO, Hwang F, Lewis GD et al (1991) Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation. Cytokine 3:551–561
Jenkins BJ (2014) Transcriptional regulation of pattern recognition receptors by JAK/STAT signaling, and the implications for disease pathogenesis. J Interferon Cytokine Res 34:750–758
Kang JG, Amar MJ, Remaley AT et al (2011) Zinc finger protein tristetraprolin interacts with CCL3 mRNA and regulates tissue inflammation. J Immunol 187:2696–2701
Kanies CL, Smith JJ, Kis C et al (2008) Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Mol Cancer Res 6:1124–1136
Katsanou V, Papadaki O, Milatos S et al (2005) HuR as a negative posttranscriptional modulator in inflammation. Mol Cell 19:777–789
Keene JD (2007) RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 8:533–543
Khabar KS (2007) Rapid transit in the immune cells: the role of mRNA turnover regulation. J Leukoc Biol 81:1335–1344
Khabar KS (2010) Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci 67:2937–2955
Khabar KS, Young HA (2007) Post-transcriptional control of the interferon system. Biochimie 89:761–769
Kontzias A, Kotlyar A, Laurence A et al (2012) Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease. Curr Opin Pharmacol 12:464–470
Lee JE, Lee JY, Wilusz J et al (2010) Systematic analysis of cis-elements in unstable mRNAs demonstrates that CUGBP1 is a key regulator of mRNA decay in muscle cells. PLoS One 5, e11201
Lee HH, Yoon NA, Vo MT et al (2012) Tristetraprolin down-regulates IL-17 through mRNA destabilization. FEBS Lett 586:41–46
Li X, Lin WJ, Chen CY et al (2012) KSRP: a checkpoint for inflammatory cytokine production in astrocytes. Glia 60:1773–1784
Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598–604
Linossi EM, Chandrashekaran IR, Kolesnik TB et al (2013) Suppressor of cytokine signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1. PLoS One 8, e70536
Lopez De Silanes I, Fan J, Galban CJ et al (2004a) Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity. Gene Expr 12:49–59
Lopez De Silanes I, Zhan M, Lal A et al (2004b) Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci USA 101:2987–2992
Lopez De Silanes I, Galban S, Martindale JL et al (2005) Identification and functional outcome of mRNAs associated with RNA-binding protein TIA-1. Mol Cell Biol 25:9520–9531
Mansfield KD, Keene JD (2009) The ribonome: a dominant force in co-ordinating gene expression. Biol Cell 101:169–181
Matsushita K, Takeuchi O, Standley DM et al (2009) Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458:1185–1190
Moudgil KD, Choubey D (2011) Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res 31:695–703
Mukherjee N, Lager PJ, Friedersdorf MB et al (2009) Coordinated posttranscriptional mRNA population dynamics during T-cell activation. Mol Syst Biol 5:288
Mukherjee N, Jacobs NC, Hafner M et al (2014) Global target mRNA specification and regulation by the RNA-binding protein ZFP36. Genome Biol 15:R12
Nepom GT, Ehlers M, Mandrup-Poulsen T (2013) Anti-cytokine therapies in T1D: concepts and strategies. Clin Immunol 149:279–285
Papadaki O, Milatos S, Grammenoudi S et al (2009) Control of thymic T cell maturation, deletion and egress by the RNA-binding protein HuR. J Immunol 182:6779–6788
Raghavan A, Bohjanen PR (2004) Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression. Brief Funct Genomic Proteomic 3:112–124
Raghavan A, Robison RL, Mcnabb J et al (2001) HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 276:47958–47965
Raghavan A, Dhalla M, Bakheet T et al (2004) Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation. Genomics 84:1002–1013
Rattenbacher B, Beisang D, Wiesner DL et al (2010) Analysis of CUGBP1 targets identifies GU-repeat sequences that mediate rapid mRNA decay. Mol Cell Biol 30:3970–3980
Ronkina N, Menon MB, Schwermann J et al (2010) MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin. Biochem Pharmacol 80:1915–1920
Saharinen P, Eklund L, Pulkki K et al (2011) VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 17:347–362
Sarkar S, Han J, Sinsimer KS et al (2011) RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes. Mol Cell Biol 31:602–615
Schott J, Stoecklin G (2010) Networks controlling mRNA decay in the immune system. Wiley Interdiscip Rev RNA 1:432–456
Seko Y, Cole S, Kasprzak W et al (2006) The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 5:299–305
Srikantan S, Gorospe M (2012) HuR function in disease. Front Biosci J Virtual Libr 17:189–205
Stellato C, Gubin MM, Magee JD et al (2011) Coordinate regulation of GATA-3 and Th2 cytokine gene expression by the RNA-binding protein HuR. J Immunol 187:441–449
Stoecklin G, Tenenbaum SA, Mayo T et al (2008) Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283:11689–11699
Stumpo DJ, Lai WS, Blackshear PJ (2010) Inflammation: cytokines and RNA-based regulation. Wiley Interdiscip Rev RNA 1:60–80
Sun L, Stoecklin G, Van Way S et al (2007) Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J Biol Chem 282:3766–3777
Talwar S, Balasubramanian S, Sundaramurthy S et al (2013) Overexpression of RNA-binding protein CELF1 prevents apoptosis and destabilizes pro-apoptotic mRNAs in oral cancer cells. RNA Biol 10:277–286
Turner M, Hodson D (2012a) Regulation of lymphocyte development and function by RNA-binding proteins. Curr Opin Immunol 24:160–165
Turner M, Hodson DJ (2012b) An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and function. Adv Immunol 115:161–185
Uehata T, Iwasaki H, Vandenbon A et al (2013) Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation. Cell 153:1036–1049
Vlasova IA, Bohjanen PR (2008) Posttranscriptional regulation of gene networks by GU-rich elements and CELF proteins. RNA Biol 5:201–207
Vlasova IA, Mcnabb J, Raghavan A et al (2005) Coordinate stabilization of growth-regulatory transcripts in T cell malignancies. Genomics 86:159–171
Vlasova IA, Tahoe NM, Fan D et al (2008) Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell 29:263–270
Vlasova-St. Louis I, Bohjanen PR (2011) Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1. Curr Opin Genet Dev 21:444–451
Vlasova-St. Louis I, Bohjanen PR (2014) Post-transcriptional regulation of cytokine signaling by AU-rich and GU-rich elements. J Interferon Cytokine Res 34:233–241
Vlasova-St. Louis I, Dickson AM, Bohjanen PR et al (2013) CELFish ways to modulate mRNA decay. Biochim Biophys Acta 1829:695–707
Von Roretz C, Di Marco S, Mazroui R et al (2011) Turnover of AU-rich-containing mRNAs during stress: a matter of survival. Wiley Interdiscip Rev RNA 2:336–347
Weichhart T, Saemann MD (2008) The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 67(Suppl 3):iii70–iii74
White EJ, Brewer G, Wilson GM (2013) Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation. Biochim Biophys Acta 1829:680–688
Winzen R, Gowrishankar G, Bollig F et al (2004) Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24:4835–4847
Winzen R, Thakur BK, Dittrich-Breiholz O et al (2007) Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets. Mol Cell Biol 27:8388–8400
Wu X, Chesoni S, Rondeau G et al (2013) Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs. Nucleic Acids Res 41:2644–2658
Yiakouvaki A, Dimitriou M, Karakasiliotis I et al (2012) Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J Clin Invest 122:48–61
Zhang L, Lee JE, Wilusz J et al (2008) The RNA-binding protein CUGBP1 regulates stability of tumor necrosis factor mRNA in muscle cells: implications for myotonic dystrophy. J Biol Chem 283:22457–22463
Acknowledgments
This work was supported by National Institutes of Health grants AI057484 and AI072068 to P.R.B. We would like to thank Eric Collins, for critical reading and scientific editing of the manuscript. Our acknowledgements to University of Minnesota Supercomputing Institute for providing the access to Ingenuity Pathway Assistant.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Vlasova-St. Louis, I., Bohjanen, P.R. (2016). Post-transcriptional Regulation of Cytokine Signaling During Inflammatory Responses. In: Menon, PhD, K., Goldstrohm, PhD, A. (eds) Post-transcriptional Mechanisms in Endocrine Regulation. Springer, Cham. https://doi.org/10.1007/978-3-319-25124-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-25124-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25122-6
Online ISBN: 978-3-319-25124-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)